Mellar P. Davis

Response shift as a common mechanism linking quality of life gains and reduced aggressive care in early palliative care trials.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: July 07, 2026

The Opioid Cage in Survivorship: Avoidance Learning and the Legacy Opioid Patient.

Journal: Journal of pain and symptom management

Published: June 29, 2026

A fragile finding: placebo and cytokines.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 17, 2026

Confounding by indication in corticosteroid use and nutritional outcomes in advanced pancreatic cancer.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: June 05, 2026

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: May 18, 2026

Routine Urine Drug Screening in Palliative Care-A Call for Evidence Before Implementation.

Journal: Journal of pain and symptom management

Published: May 11, 2026

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Journal: Journal of pain and symptom management

Published: May 11, 2026

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 10, 2026

Intensive nursing intervention: what is the post treatment effect size on anxiety and depression?

Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Published: April 07, 2026

From Symptom Control to Precision Supportive Oncology: Integrating Artificial Intelligence in Supportive Oncology for Gastrointestinal Cancers.

Journal: Current oncology reports

Published: April 07, 2026

Response shift as a common mechanism linking quality of life gains and reduced aggressive care in early palliative care trials.

Response shift as a common mechanism linking quality of life gains and reduced aggressive care in early palliative care trials.

The Opioid Cage in Survivorship: Avoidance Learning and the Legacy Opioid Patient.

The Opioid Cage in Survivorship: Avoidance Learning and the Legacy Opioid Patient.

A fragile finding: placebo and cytokines.

A fragile finding: placebo and cytokines.

Confounding by indication in corticosteroid use and nutritional outcomes in advanced pancreatic cancer.

Confounding by indication in corticosteroid use and nutritional outcomes in advanced pancreatic cancer.

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Substance use monitoring in supportive oncology: surveillance is not a clinical outcome, and policing is not a therapeutic framework.

Routine Urine Drug Screening in Palliative Care-A Call for Evidence Before Implementation.

Routine Urine Drug Screening in Palliative Care-A Call for Evidence Before Implementation.

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Routine Urine Drug Screening in Palliative Care - A Call for Evidence Before Implementation.

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Does the Edmonton Symptom Assessment Scale rule in or rule out anxiety and depression?

Intensive nursing intervention: what is the post treatment effect size on anxiety and depression?

Intensive nursing intervention: what is the post treatment effect size on anxiety and depression?

From Symptom Control to Precision Supportive Oncology: Integrating Artificial Intelligence in Supportive Oncology for Gastrointestinal Cancers.

From Symptom Control to Precision Supportive Oncology: Integrating Artificial Intelligence in Supportive Oncology for Gastrointestinal Cancers.

MASCC score and neutropenic complications: what is the likelihood?

MASCC score and neutropenic complications: what is the likelihood?

Methodological considerations and biological context.

Methodological considerations and biological context.